AFP announces new bureau in North Korea
Agence France-Presse (AFP) announced Tuesday it will open a bureau in Pyongyang, becoming only the second global news agency to establish a permanent presence in the North Korean capital.
Jerusalem (AFP) | 12/07/2025 - 18:55:57 | Israeli political official accuses Hamas of sabotaging Gaza ceasefire talks
Paris (AFP) | 12/07/2025 - 18:23:22 | Macron calls on EU to 'defend European interests' in US tariff talks
Mexico City (AFP) | 12/07/2025 - 16:55:57 | Mexico slams Trump threat of 30% tariffs as 'unfair deal': statement
Tehran (AFP) | 12/07/2025 - 16:07:27 | Iran says any nuclear deal must respect 'right' to enrich uranium
Brussels (AFP) | 12/07/2025 - 15:56:54 | EU chief slams Trump tariff threat, says 'ready' to keep working on deal
Tehran (AFP) | 12/07/2025 - 15:47:07 | Iran says 'examining' details for potential nuclear talks
Tehran (AFP) | 12/07/2025 - 15:39:26 | Iran says 'military capabilities' not up for negotiation in nuclear talks
Damascus (AFP) | 12/07/2025 - 15:28:38 | Syrian, Israeli officials to meet in Baku: diplomatic source in Damascus
Tehran (AFP) | 12/07/2025 - 15:05:13 | Iran says sanctions snapback could 'end' Europe's role in nuclear issue
Geneva (AFP) | 12/07/2025 - 15:04:34 | Fuel shortages in Gaza at 'critical levels', UN warns
Agence France-Presse (AFP) announced Tuesday it will open a bureau in Pyongyang, becoming only the second global news agency to establish a permanent presence in the North Korean capital.
AFP takes part to the 7th photography festival in Leipzig f/stop, Germany, from June 25th until July 3rd, 2016.
The Asian Productivity Organization (APO) convened the 67th Session of the Governing Body (GBM), 20–22 May 2025 in Jakarta, hosted by the Government of the Republic of Indonesia. This annual session brought together over 50 delegates representing APO member governments to discuss the APO’s strategic direction and ensure the organization’s continued credibility, effectiveness, and relevance amid a rapidly evolving productivity landscape. This press release features multimedia. View the full rel...
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, HKEX: 02315) today announced that the key technology of its independently developed RenMab™ fully human antibody mouse platform has been granted an invention patent by the Japan Patent Office (JPO). This milestone marks a significant step in strengthening the global intellectual property portfolio of the RenMice® fully human antibody platform family. It underscores the continued advancement of Biocytogen’s comprehensive ...